WallStreetZenWallStreetZen

NASDAQ: RVNC
Revance Therapeutics Inc Stock Forecast, Predictions & Price Target

Analyst price target for RVNC

Based on 6 analysts offering 12 month price targets for Revance Therapeutics Inc.
Min Forecast
$8.00+169.36%
Avg Forecast
$10.00+236.7%
Max Forecast
$12.00+304.04%

Should I buy or sell RVNC stock?

Based on 6 analysts offering ratings for Revance Therapeutics Inc.
Buy
Strong Buy
2 analysts 33.33%
Buy
2 analysts 33.33%
Hold
2 analysts 33.33%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their RVNC stock forecasts and price targets.

RVNC stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-05-13
lockedlocked$00.00+00.00%2024-05-13
lockedlocked$00.00+00.00%2024-05-10
lockedlocked$00.00+00.00%2024-05-10
lockedlocked$00.00+00.00%2024-05-10
Barclays
Bottom 10%
10
Strong BuyMaintains$10.00+236.70%2024-01-29

1 of 1

Forecast return on equity

Is RVNC forecast to generate an efficient return?
Company
-52.93%
Industry
75.86%
Market
79.52%
RVNC's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is RVNC forecast to generate an efficient return on assets?
Company
10.28%
Industry
30.88%
RVNC is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

RVNC earnings per share forecast

What is RVNC's earnings per share in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
-$1.83
Avg 2 year Forecast
-$0.74
Avg 3 year Forecast
$0.33

RVNC revenue forecast

What is RVNC's revenue in the next 3 years based on estimates from 5 analysts?
Avg 1 year Forecast
$275.6M+16.46%
Avg 2 year Forecast
$380.1M+60.62%
Avg 3 year Forecast
$485.7M+105.22%
RVNC's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

RVNC revenue growth forecast

How is RVNC forecast to perform vs Biotechnology companies and vs the US market?
Company
27.06%
Industry
35.1%
Market
9.92%
RVNC's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
RVNC's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

RVNC vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
RVNC$2.97$10.00+236.70%Buy
XOMA$26.70$57.00+113.48%Buy
AVIR$3.70N/AN/A
STRO$3.85$12.57+226.52%Strong Buy
AVXL$3.73$40.00+972.39%Buy

Revance Therapeutics Stock Forecast FAQ

Is Revance Therapeutics Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 6 Wall Street analysts covering (NASDAQ: RVNC) stock is to Buy RVNC stock.

Out of 6 analysts, 2 (33.33%) are recommending RVNC as a Strong Buy, 2 (33.33%) are recommending RVNC as a Buy, 2 (33.33%) are recommending RVNC as a Hold, 0 (0%) are recommending RVNC as a Sell, and 0 (0%) are recommending RVNC as a Strong Sell.

If you're new to stock investing, here's how to buy Revance Therapeutics stock.

What is RVNC's earnings growth forecast for 2024-2026?

(NASDAQ: RVNC) Revance Therapeutics's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 13.83%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 18.77%.

Revance Therapeutics's earnings in 2024 is -$317,345,000.On average, 1 Wall Street analyst forecast RVNC's earnings for 2024 to be -$191,140,759, with the lowest RVNC earnings forecast at -$191,140,759, and the highest RVNC earnings forecast at -$191,140,759. On average, 2 Wall Street analysts forecast RVNC's earnings for 2025 to be -$76,769,649, with the lowest RVNC earnings forecast at -$92,959,167, and the highest RVNC earnings forecast at -$60,580,131.

In 2026, RVNC is forecast to generate $34,468,006 in earnings, with the lowest earnings forecast at $34,468,006 and the highest earnings forecast at $34,468,006.

What is RVNC's revenue growth forecast for 2024-2026?

(NASDAQ: RVNC) Revance Therapeutics's forecast annual revenue growth rate of 27.06% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 35.1%, and while it is forecast to beat the US market's average forecast revenue growth rate of 9.92%.

Revance Therapeutics's revenue in 2024 is $236,645,000.On average, 5 Wall Street analysts forecast RVNC's revenue for 2024 to be $28,785,798,254, with the lowest RVNC revenue forecast at $27,967,130,896, and the highest RVNC revenue forecast at $29,705,153,969. On average, 5 Wall Street analysts forecast RVNC's revenue for 2025 to be $39,701,397,853, with the lowest RVNC revenue forecast at $37,263,047,574, and the highest RVNC revenue forecast at $43,496,534,173.

In 2026, RVNC is forecast to generate $50,725,623,893 in revenue, with the lowest revenue forecast at $47,381,078,411 and the highest revenue forecast at $56,778,205,687.

What is RVNC's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: RVNC) forecast ROA is 10.28%, which is lower than the forecast US Biotechnology industry average of 30.88%.

What is RVNC's Price Target?

According to 6 Wall Street analysts that have issued a 1 year RVNC price target, the average RVNC price target is $10.00, with the highest RVNC stock price forecast at $12.00 and the lowest RVNC stock price forecast at $8.00.

On average, Wall Street analysts predict that Revance Therapeutics's share price could reach $10.00 by May 13, 2025. The average Revance Therapeutics stock price prediction forecasts a potential upside of 236.7% from the current RVNC share price of $2.97.

What is RVNC's Earnings Per Share (EPS) forecast for 2024-2026?

(NASDAQ: RVNC) Revance Therapeutics's current Earnings Per Share (EPS) is -$3.64. On average, analysts forecast that RVNC's EPS will be -$1.83 for 2024, with the lowest EPS forecast at -$1.83, and the highest EPS forecast at -$1.83. On average, analysts forecast that RVNC's EPS will be -$0.74 for 2025, with the lowest EPS forecast at -$0.89, and the highest EPS forecast at -$0.58. In 2026, RVNC's EPS is forecast to hit $0.33 (min: $0.33, max: $0.33).

What is RVNC's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: RVNC) forecast ROE is -52.93%, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.